Handelsbanken Fonder Ab Exelixis, Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Exelixis, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 78,466 shares of EXEL stock, worth $2.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

78,466

Previous 61,266 28.07%

Holding current value

$2.79 Million

Previous $1.38 Million 47.86%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$21.96 - $27.6 $377,712 - $474,720	17,200 Added 28.07%	78,466 $2.04 Million
Q2 2024 Aug 05, 2024	SELL	$20.34 - $23.73 $63,054 - $73,563	-3,100 Reduced 4.82%	61,266 $1.38 Million
Q4 2023 Feb 01, 2024	BUY	$19.25 - $24.13 $177,100 - $221,996	9,200 Added 16.68%	64,366 $1.54 Million
Q2 2023 Aug 02, 2023	BUY	$18.17 - $20.48 $192,602 - $217,088	10,600 Added 23.78%	55,166 $1.05 Million
Q3 2022 Oct 27, 2022	SELL	$15.68 - $22.27 $45,472 - $64,583	-2,900 Reduced 6.11%	44,566 $699,000
Q1 2022 May 11, 2022	SELL	$17.03 - $22.67 $229,905 - $306,045	-13,500 Reduced 22.14%	47,466 $1.08 Million
Q3 2021 Nov 10, 2021	BUY	$16.3 - $21.14 $71,720 - $93,016	4,400 Added 7.78%	60,966 $1.29 Million
Q2 2021 Aug 03, 2021	BUY	$17.95 - $25.56 $78,980 - $112,464	4,400 Added 8.43%	56,566 $1.03 Million
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $858,652 - $1.43 Million	52,166 New	52,166 $1.24 Million
Q4 2018 Jan 31, 2019	SELL	$13.65 - $21.8 $1.21 Million - $1.94 Million	-89,000 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$15.87 - $22.4 $3.79 Million - $5.35 Million	-239,000 Reduced 72.87%	89,000 $1.58 Million
Q2 2018 Jul 11, 2018	BUY	$18.56 - $22.45 $352,640 - $426,550	19,000 Added 6.15%	328,000 $7.06 Million
Q1 2018 May 18, 2018	BUY	$22.15 - $31.89 $841,700 - $1.21 Million	38,000 Added 14.02%	309,000 $6.84 Million
Q4 2017 Feb 08, 2018	SELL	$24.23 - $30.93 $1.41 Million - $1.79 Million	-58,000 Reduced 17.63%	271,000 $8.24 Million
Q3 2017 Oct 24, 2017	BUY	$23.35 - $29.24 $7.68 Million - $9.62 Million	329,000	329,000 $7.97 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Exelixis, Inc. Transaction History